SmPC- Telmisartan/Hydrochlorothiazide 80mg/12.5mg Tablets: Change history
View Summary of Product Characteristics (SmPC- Telmisartan/Hydrochlorothiazide 80mg/12.5mg Tablets)
Last updated on this site: 14 Apr 2023
Variation description: Type IB (C.I.3.z) variation application to update SmPC section 5.3 for `incresed risk of skin cancer' as per CMDh minutes for the meeting updated on 8-10 November 2022.
SmPC sections updated: 5.3, 9, 10.
View Summary of Product Characteristics (SmPC- Telmisartan/Hydrochlorothiazide 80mg/12.5mg Tablets)
Last updated on this site: 14 Apr 2023
Variation description: Type IB (C.I.3.z) variation application to update SmPC section 5.3 for `incresed risk of skin cancer' as per CMDh minutes for the meeting updated on 8-10 November 2022.
SmPC sections updated: 5.3, 9, 10.
-
Changes: (Updated: 14 Apr 2023)
Variation description: Type IB (C.I.3.z) variation application to update SmPC section 5.3 for `incresed risk of skin cancer' as per CMDh minutes for the meeting updated on 8-10 November 2022.
SmPC sections updated: 5.3, 9, 10.
-
Changes: (Updated: 22 Sep 2022)
initial upload